Mark D. Deboer, Md, Msc., Mcr

This study tested whether a faster-acting insulin (Lyumjev) works better than standard insulins (Humalog or Novolog) in an automated insulin pump system for teens with type 1 diabetes. Eleven adolescents aged 12 to 22 took part. Researchers used a special conversion factor to set…